The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products. The Board consists of five members who possess expertise in the fields of either health care economics or clinical medicine. Members of the board are appointed by MD State Government officials. The board is supported by professional staff including an executive director and general counsel.
For more information on PDAB, please visit our website.